Insulin degludec/Insulin aspart（Beijing Sl Pharma）
德谷胰岛素/门冬胰岛素（北京双鹭药业）
Report date: 2023/03/08 16:43:34
Base Information
Drug NameInsulin degludec/Insulin aspart（Beijing Sl Pharma）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Sl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksKEGG